<?xml version="1.0" encoding="UTF-8"?>
<ref id="B83">
 <label>83.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Manohar</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Loh</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Athira</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Nachimuthu</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Hua</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Welburn</surname>
    <given-names>SC</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics?</article-title>
  <source>Front Microbiol.</source> (
  <year>2020</year>) 
  <volume>11</volume>:
  <fpage>1434</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fmicb.2020.01434</pub-id>
  <?supplied-pmid 32733404?>
  <pub-id pub-id-type="pmid">32733404</pub-id>
 </mixed-citation>
</ref>
